Aman, Jay-ar A.
HRN: 11-30-36 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/20/2023
CEFTRIAXONE 1G (VIAL)
02/20/2023
02/26/2023
IV
2g
Q24
PCAP
Waiting Final Action
Indication: Empiric Type of Infection: URTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes